Dicerna Pharmaceuticals Inc Banner Image

Dicerna Pharmaceuticals Inc

  • Ticker DRNA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Dicerna Pharmaceuticals Inc Logo Image
  • 11-50 Employees
  • Based in Cambridge, Massachusetts
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encodingMore the liver enzyme glycolate oxidase; and other rare inherited diseases involving genes expressed in the liver.
4.8 / 5.0 (165)

Dicerna Pharmaceuticals Inc reports have an aggregate usefulness score of 4.8 based on 165 reviews.

Dicerna Pharmaceuticals Inc

Most Recent Annual Report

Dicerna Pharmaceuticals Inc
MOST RECENT 2020 Annual Report and Form 10K

Dicerna Pharmaceuticals Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Dicerna Pharmaceuticals Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!